期刊文献+

儿童动脉导管未闭介入封堵后血小板减少的危险因素和预测模型 被引量:1

Risk factors and prediction model of thrombocytopenia in children with patent ductus arteriosus after transca-theter closure
原文传递
导出
摘要 目的探讨儿童动脉导管未闭(PDA)介入封堵后血小板减少的危险因素,并建立PDA介入封堵后血小板减少预测模型。方法选取2016年11月至2020年1月于南京医科大学附属儿童医院就诊的39例PDA介入封堵后发生血小板减少的病例,并以同时期就诊的138例PDA介入封堵后未发生血小板减少病例作为对照,采用Logistic回归模型探索PDA介入封堵后发生血小板减少可能的危险因素,建立随机森林模型预测PDA介入封堵后血小板减少的发生。结果患儿PDA介入封堵后,发生血小板减少的时间为术后1~7 d,血小板恢复时间为术后2~22 d。单因素Logistic回归模型表明,患儿动脉导管肺动脉端内径大小(OR=9.54,95%CI:2.08~48.84,P=0.004)和术前血小板计数(OR=0.99,95%CI:0.98~0.99,P=0.001)与PDA介入封堵后发生血小板减少相关。随机森林模型显示,动脉导管肺动脉端内径对PDA介入封堵后发生血小板减少的相对重要性最大。结论患儿动脉导管内径大是导致PDA封堵术后血小板减少的重要危险因素,术前血小板计数增高是PDA封堵术后血小板减少的相对保护因素,动脉导管肺动脉端内径对预测PDA介入封堵后发生血小板减少的相对重要性最大。 Objective To explore the risk factors of thrombocytopenia in children with patent ductus arteriosus(PDA)after transcatheter closure,and to establish a prediction model of thrombocytopenia after transcatheter closure of PDA.Methods A total of 39 PDA children with thrombocytopenia after transcatheter closure treated in Children′s Hospital of Nanjing Medical University from November 2016 to January 2020 were selected.During the same period,138 PDA children without thrombocytopenia after transcatheter closure were included in the control group.Logistic regression model was used to explore the possible risk factors of thrombocytopenia after transcatheter closure in PDA children,and a random forest model was established to predict the occurrence of thrombocytopenia after transcatheter closure of PDA.Results After transcatheter closure of PDA,children developed thrombocytopenia within 1 to 7 days,and the platelet count recovered within 2 to 22 days.Logistic regression model suggested that the diameter of pulmonary artery end of arterial catheter(OR=9.54,95%CI:2.08-48.84,P=0.004)and preoperative platelet count(OR=0.99,95%CI:0.98-0.99,P=0.001)were correlated with the occurrence of thrombocytopenia after transcatheter closure of PDA.The random forest model indicated that PDA inner diameter was the most important factor for predicting the occurrence of thrombocytopenia after transcatheter closure of PDA.Conclusions A large diameter of arterial duct is an important risk factor and increased preoperative platelet count is a protective factor for thrombocytopenia after transcatheter closure of PDA.Diameter is of the greatest significance in predicting the occurrence of thrombocytopenia after transcatheter closure of PDA.
作者 陈金龙 杨世伟 秦玉明 程学英 Chen Jinlong;Yang Shiwei;Qin Yuming;Cheng Xueying(Department of Cardiology,Children′s Hospital of Nanjing Medical University,Nanjing 210008,China)
出处 《中华实用儿科临床杂志》 CAS CSCD 北大核心 2021年第19期1466-1469,共4页 Chinese Journal of Applied Clinical Pediatrics
基金 国家自然科学基金(81670284)。
关键词 动脉导管未闭 介入封堵 血小板减少 儿童 Patent ductus arteriosus Transcatheter closure Thrombocytopenia Child
  • 相关文献

参考文献4

二级参考文献15

  • 1Li P, Chen F, Zhao X, et al. Occurrence and clinical significance of in hospital acquired thrombocytopenia in patients undergoing transcatheter device closure for congenital heart defect [J]. ThrombRes, 2012,130(6):882- 888.
  • 2Zhou D, Zhang X, Pan W, et al. Decline in platelet count after perculaneous transeatheter closure of congenital heart disease [J]. Acta Cardiol, 2013,68(4) :373 -379.
  • 3Zeng XC, Wu WF, Huang K, et al. Enhanced prothrombin formation and platelet activation in Chinese patients after transcatheter closure of atrial septal defect [J]. Clin Cardiol, 2010,33(7) :E6- E9.
  • 4Knepp MD, Rocchini AP, Lloyd TR, et al. Long term follow up of secundum atrial septal defect closure with the amplatzer seplal occluder [J]. Congenit Heart Dis, 2010,5(1):32 -37.
  • 5Zhang P, Zhu XY. Severe thrombocytopenia complicating transcatheter occlusion of a patent ductus arteriosus [J]. J Invasive Cardiol, 2013,25(5) :E88- E92.
  • 6Yu MI., Huang XM, Wang JF, et al. Safety and efficacy of transcatheter closure of large patent ductus arteriosus inaduhs with a seII expandable occiuder [J]. Heart Vessels, 2009,24 (6) : 440-445.
  • 7Lee GM, Arepally GM. Diagnosis and management of heparin induced thrombocytopenia [J]. Hematol Oncol Clin North Am, 2013,27(3):541- 563.
  • 8Vales L, Kanei Y, Ephrem G, et al. fntra-aortic balloon pump use and outcomes with current therapies [J]. J Invasive Cardiol, 2011,23(3) :116-119.
  • 9De Labriolle A, Bonello L, Lemesle G, et al. Decline in platelet count in patients treated by percutaneous coronary intervention: definition, incidence, prognostic importance, and predictive faetors [J]. Eur Heart J, 2010, 31 (9): 1079-1087.
  • 10Bream-Rouwenhorst HR, Hobbs RA, Horwitz PA. Throm- bocytopenia in patients treated with heparin, combination antiplatelet therapy, and intra-aortic balloon pump counterpulsation [J]. J lnterv Cardiol, 2008, 21 (4): 350- 356.

共引文献29

同被引文献19

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部